Supplementary Fig. S3 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Xiangyan Zhang
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
41Publications signalées
112Citations signalées
0Affiliations récentes
Les domaines associés
Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersCancer Research and TreatmentsPeptidase Inhibition and AnalysisCancer, Hypoxia, and Metabolism
Les publications récentes
Supplementary Fig. S9 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Fig. S6 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Fig. S8 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Table S3 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Table S2 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Fig. S5 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Fig. S10 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Fig. S2 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Table S4 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Table S1 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
Supplementary Fig. S7 from Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer
Guofeng Ma, Huiqing Jia, Zhiqiang Li, Xiangyan Zhang et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.